Hikma Pharmaceuticals
Website: Hikma Pharmaceuticals
Index: FTSE 100
EPIC: HIK
Sector: Pharmaceuticals & Biotechnology
Subsector: Pharmaceuticals
Market Cap:
£4.63B
Payout Frequency: Semi-Annual
Hikma Pharmaceuticals Annual Dividend Yield - 2.74%
Dividends Used in Calculation:
21/03/2024 |
03/05/2024 |
Final |
47.00¢ |
USX |
15/08/2024 |
20/09/2024 |
Interim |
32.00¢ |
USX |
Total (Annual Dividends Per Share):
58.39p
(Using exchange rate on 03/06/2025 $1 = £0.73915)
Dividend Yield = Annual Dividends Per Share (58.39p) ÷ Share Price (2130p) = 2.74%
Hikma Pharmaceuticals Dividend History
20/03/2025 | 01/05/2025 | Final | 48.00¢ | USX |
15/08/2024 | 20/09/2024 | Interim | 32.00¢ | USX |
21/03/2024 | 03/05/2024 | Final | 47.00¢ | USX |
10/08/2023 | 15/09/2023 | Interim | 25.00¢ | USX |
23/03/2023 | 05/05/2023 | Final | 37.00¢ | USX |
18/08/2022 | 20/09/2022 | Interim | 19.00¢ | USX |
18/08/2022 | 19/09/2022 | Interim | 19.00¢ | USX |
17/03/2022 | 28/04/2022 | Final | 36.00¢ | USX |
19/08/2021 | 20/09/2021 | Interim | 18.00¢ | USX |
18/03/2021 | 26/04/2021 | Final | 34.00¢ | USX |
20/08/2020 | 21/09/2020 | Interim | 16.00¢ | USX |
19/03/2020 | 07/05/2020 | Final | 30.00¢ | USX |
22/08/2019 | 23/09/2019 | Interim | 14.00¢ | USX |
04/04/2019 | 22/05/2019 | Final | 26.00¢ | USX |
23/08/2018 | 21/09/2018 | Interim | 12.00¢ | USX |
05/04/2018 | 24/05/2018 | Final | 23.00¢ | USX |
24/08/2017 | 22/09/2017 | Interim | 11.00¢ | USX |
06/04/2017 | 25/05/2017 | Final | 22.00¢ | USX |
01/09/2016 | 30/09/2016 | Interim | 11.00¢ | USX |
07/04/2016 | 19/05/2016 | Final | 21.00¢ | USX |
27/08/2015 | 25/09/2015 | Interim | 11.00¢ | USX |
16/04/2015 | 21/05/2015 | Special | 6.00¢ | USX |
16/04/2015 | 21/05/2015 | Final | 15.00¢ | USX |
27/08/2014 | 26/09/2014 | Special | 4.00¢ | USX |
27/08/2014 | 26/09/2014 | Interim | 7.00¢ | USX |
23/04/2014 | 22/05/2014 | Special | 4.00¢ | USX |
23/04/2014 | 22/05/2014 | Final | 13.00¢ | USX |
04/09/2013 | 07/10/2013 | Interim | 7.00¢ | USX |
04/09/2013 | 07/10/2013 | Special | 3.00¢ | USX |
29/08/2012 | 08/10/2012 | Interim | 6.00¢ | USX |
17/04/2012 | 23/05/2012 | Final | 1.00¢ | USX |
07/09/2011 | 13/10/2011 | Interim | 5.50¢ | USX |
18/04/2011 | 24/05/2011 | Final | 7.50¢ | USX |
08/09/2010 | 14/10/2010 | Interim | 5.50¢ | USX |
13/04/2010 | 26/05/2010 | Final | 7.50¢ | USX |
16/09/2009 | 16/10/2009 | Interim | 4.50¢ | USX |
14/04/2009 | 27/05/2009 | Final | 6.50¢ | USX |
17/09/2008 | 17/10/2008 | Interim | 3.50¢ | USX |
29/04/2008 | 02/06/2008 | Final | 4.00¢ | USX |
26/09/2007 | 26/10/2007 | Interim | 3.50¢ | USX |
30/04/2007 | 02/06/2007 | Final | 4.00¢ | USX |
27/09/2006 | 27/10/2006 | Interim | 3.00¢ | USX |
16/05/2006 | 18/06/2006 | Final | 4.00¢ | USX |
26/04/2005 | 30/05/2005 | Final | 0.89¢ | USX |
2024 | 32.000 | 48.000 | | USX | 80.000 | 11.11 |
2023 | 25.000 | 47.000 | | USX | 72.000 | -4.00 |
2022 | 38.000 | 37.000 | | USX | 75.000 | 38.88 |
2021 | 18.000 | 36.000 | | USX | 54.000 | 8.00 |
2020 | 16.000 | 34.000 | | USX | 50.000 | -28.57 |
2019 | 14.000 | 56.000 | | USX | 70.000 | 100.00 |
2018 | 12.000 | 23.000 | | USX | 35.000 | 6.06 |
2017 | 11.000 | 22.000 | | USX | 33.000 | 3.12 |
2016 | 11.000 | 21.000 | | USX | 32.000 | 0.00 |
2015 | 11.000 | 15.000 | 6.000 | USX | 32.000 | 14.28 |
2014 | 7.000 | 13.000 | 8.000 | USX | 28.000 | 180.00 |
2013 | 7.000 | | 3.000 | USX | 10.000 | 42.85 |
2012 | 6.000 | 1.000 | | USX | 7.000 | -46.15 |
2011 | 5.500 | 7.500 | | USX | 13.000 | 0.00 |
2010 | 5.500 | 7.500 | | USX | 13.000 | 18.18 |
2009 | 4.500 | 6.500 | | USX | 11.000 | 46.66 |
2008 | 3.500 | 4.000 | | USX | 7.500 | 0.00 |
2007 | 3.500 | 4.000 | | USX | 7.500 | 7.14 |
2006 | 3.000 | 4.000 | | USX | 7.000 | 686.51 |
2005 | | 0.890 | | USX | 0.890 | |
Hikma Pharmaceuticals Dividend Calculator
Hikma Pharmaceuticals Dividend Growth
Dividend Growth (1Y) |
9.34%
|
Dividend CAGR (5Y) |
10.46%
|
Years of Growth |
3
|
Payout Ratio |
48.75%
|
Buyback Yield |
-0.51%
|
Shareholder Yield |
2.24%
|
Hikma Pharmaceuticals Valuation & Profitability
P/E Ratio (TTM) |
16.33
|
Forward P/E |
12.37
|
P/FCF |
14.52
|
Earnings Yield |
6.19%
|
FCF Yield |
6.88%
|
ROE |
15.98%
|
ROCE |
19.27%
|
Profit Margin |
11.48%
|
Operating Margin |
19.44%
|
Gross Margin |
45.25%
|